iBio Inc has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 3, 2024. The company seeks to have the registration become effective on August 6, 2024, at 4:00 p.m. Eastern Time. This request was communicated through a letter addressed to Daniel Crawford at the SEC, with the understanding that the company acknowledges its responsibilities under federal securities laws. iBio Inc has authorized Leslie Marlow of Blank Rome LLP to modify or withdraw the acceleration request if necessary. The SEC staff has been asked to contact Leslie Marlow or Melissa Palat Murawsky for any inquiries and to notify them once the acceleration has been granted.

iBio Inc has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 3, 2024. The company seeks to have the registration become effective on August 6, 2024, at 4:00 p.m. Eastern Time. This request was communicated through a letter addressed to Daniel Crawford at the SEC, with the understanding that the company acknowledges its responsibilities under federal securities laws. iBio Inc has authorized Leslie Marlow of Blank Rome LLP to modify or withdraw the acceleration request if necessary. The SEC staff has been asked to contact Leslie Marlow or Melissa Palat Murawsky for any inquiries and to notify them once the acceleration has been granted.